摘要
膀胱癌的发病率居泌尿系恶性肿瘤的第一位,据美国1998年的资料显示约60000患者患膀胱肿瘤,其中70%~80%为恶性肿瘤[1].
出处
《现代泌尿外科杂志》
CAS
2002年第3期181-183,共3页
Journal of Modern Urology
参考文献21
-
1Lacombe L,Dalbangni G, Zhang ZF, et al. Overexpression of P53 protein in a high - risk population of patients with superficial bladde cancer before and after Bacillus Calmette - Guerin theropy: correla tion to clinical outcome. J Clin Oncol, 1996, 14:2646 - 2652.
-
2Huber RP. Tumor markers in bladder cancer. Urology, 1984, 23(3Suppl): 10 - 14.
-
3Sarosdy MF, De Vere White RW, Soloway MS. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol,1995, 154:379 - 383.
-
4Ellis WJ, Blumenstein BA, Ishak LM. Clinical evaluation of the BAT TRAK assay and comparrison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. Urology,1997,50:882 - 887.
-
5Keesee SK, Briggman JV, Thill G, et al. Utilization of nuclear matrix proteins for cancer diagnosis. Crit Rev Eukaryot Gone Expr.1996,6:189 - 214.
-
6Soloway MS, Briggman V, Carpinito GA,et al. Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring tranisitional cell carcinoma of the urinary tract following surgical treatment. J Urol, 1996, 156:363-367.
-
7Lokeshwar VB, Obek C, Soloway MS, et al. Tumor associated hyaluronic acid:A new sensitive and specific urine marker for bladder cancer. Cancer Res,1997, 57:773 - 777.
-
8Knudson W, Biswas C, Li XQ, et al. The role and regulation of tumor associated hyaluronan. Ciba Foundation Symp, 1989, 143:150-159.
-
9Pham HT, Block NL, Lokeshwar VB. Tumor- derived hyaluronidise:A diagnostic urine marker for highgrade bladder cancer. Cancer Res, 1997,57: 778 - 783.
-
10Lokeshwar VB, Block NL. HA- HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade. Urol Clin North Am, 2000, 27(1) :53 - 61.
同被引文献9
-
1[1]Soloway MS, Briggman JV, Carpinito GA, et al. Use of a new marker, urinary NMP22 , in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment [J]. J Urol, 1996, 156(2 Pt 1): 363-367.
-
2[2]Carpinito GA, Stadler WM, Briggman JV, et al. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract [J]. J Urol, 1996, 156(4): 1280-1285.
-
3[4]Keesee SK, Briggman JV, Thill G, et al. Utilization of nuclear matrix protein for cancer diagnosis [J]. Crit Rev Eukaryot Gene Expr, 1996, 6(2-3):189-214.
-
4[5]Sharma S, Zippc CD, Pandrangi L, et al. Exclusion criteria enhance the specificity and position predictive value of NMP22 and BTA stat [J]. J Urol, 1999,162(1):53-57.
-
5[6]Serretta V, Presti DL, Vasile P, et al. Urinary NMP22 for the detection of recorrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients [J]. Urology, 1998, 52(5): 793-796.
-
6Soloway MS,Briggman JV, Carpinmto GA,et al.Use of anew marker,urinary NMP22 ,in the detectiong of occult ot rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment[J].J Urol, 1996,156(2 pt1) :363.
-
7Carpinito GA, stadler WM,briggman JV, et al.Urinary nuclear matrix protein as a marker for transitionas call carcinoma of the urinary tract[J].J Uorl, 1996,, 156(4): 1280.
-
8Sharma S,Cippe CD,pandrang L,et al.Exclusion criteriaenhance the xpecificity and position predictive value of NMP22 and BTA stat[J].J Urol, 1999,162(1): 53.
-
9Serretta V,Presti DL, Vasile P,et al.Urinary NMP22 for the detection of recurrence after traneurethral resetion of transitional cell carcinoma of the bladder.Experience on 137 patients[J].Urology, 1998, 52(5): 793.
引证文献2
-
1龚百生,尹华军,黄翔,符本琪,陈照祥.核基质蛋白22诊断膀胱移行细胞癌的价值[J].现代医药卫生,2005,21(16):2094-2095. 被引量:1
-
2黄翔,龚百森,符本琪,佘伟,潘慈康.尿核基质蛋白22检测在膀胱癌诊断中的应用[J].现代泌尿外科杂志,2004,9(2):73-75. 被引量:1
二级引证文献2
-
1兰卫华,靳风烁,王洛夫,张尧,万江华,叶锦.核基质蛋白22对国人膀胱癌诊断效能的Meta分析[J].循证医学,2007,7(4):224-229.
-
2黄翔,邹建华,廖勇,龚百生,符本琪,屈艺.尿液中核基质蛋白22联合端粒酶活性检测在膀胱癌诊断中的作用[J].现代泌尿生殖肿瘤杂志,2009,1(4):234-236. 被引量:3
-
1白守民,梁碧玲,崔念基.基因标记物在头颈部肿瘤中的应用[J].国外医学(肿瘤学分册),2001,28(3):207-209.
-
2虞颂庭,张景全.对免疫组织化学及流式细胞术测定膀胱肿瘤标记物之评价[J].中华泌尿外科杂志,1989,10(4):213-216.
-
3毕长富,张克荣,董浩,王占海,夏增学.尿脱落细胞CK20检测对膀胱癌诊断的意义[J].河北医药,2010,32(12):1537-1538. 被引量:1
-
4都卫国,靳风烁.膀胱肿瘤的新标记物[J].国外医学(泌尿系统分册),1999,19(4):154-155. 被引量:2
-
5熊林,谭万龙.尿液中膀胱肿瘤标记物的研究进展[J].国外医学(泌尿系统分册),2005,25(6):792-796.
-
6徐春国,杨彬.膀胱肿瘤标记物的研究进展[J].医学与哲学(B),2012,33(12):40-41. 被引量:5
-
7李韬,赵金伟,葛巨刚,李晨玉.外周血基因标记物mRNA表达与老年癌性肠梗阻肝转移的相关性[J].中国老年学杂志,2013,33(13):3020-3021.
-
8叶锦,靳风烁.尿液中膀胱肿瘤标记物的研究现状及进展[J].现代医药卫生,2010,26(3):400-402. 被引量:2
-
9张潮.新型膀胱癌肿瘤标记物的研究进展[J].世界最新医学信息文摘,2015,15(71).
-
10陈文轩,林毅,李黎明,强万明.NMP22在尿路上皮癌诊断中的临床应用[J].天津医科大学学报,2003,9(3):418-420.